Overview

Safety and Efficacy of Abatacept in Subjects With Chronic Urticaria Who Have Had an Inadequate Response to Anti-histamine Therapy

Status:
Completed

Trial end date:
2013-03-01

Target enrollment:

Participant gender:

Summary

This study is being done to find out if a drug called Abatacept (Orencia ®) is safe and effective in treating people with chronic urticaria (persistent hives).

Phase:

Phase 1/Phase 2

Details

Lead Sponsor:

Johns Hopkins University

Collaborator:

Bristol-Myers Squibb

Treatments:

Abatacept
Histamine
Histamine Antagonists
Histamine H1 Antagonists
Histamine phosphate